New avenue for antidepressant therapy discovered

18 Jan 2017

Researchers have made a groundbreaking discovery revealing new molecular information on how the brain regulates depression and anxiety. In so doing, they identified a new molecule that alleviates anxiety and depressive behaviour in rodents. The research, led by Eleanor Coffey, Research Director at Åbo Akademi University in Finland, is a collaborative effort between scientists in Finland and the US.    

The researchers found that a protein called JNK, when active, represses the generation of new neurons in the hippocampus, a part of the brain that controls emotions and learning. By inhibiting JNK solely in newly generated nerve cells in the hippocampus, the researchers were able to alleviate anxiety and depressive behaviour in mice. This previously unknown mechanism brings fresh insight into how the brain works to regulate mood and indicates that inhibitors of JNK, such as the one used here, can provide a new avenue for antidepressant and anxiolytic drug development.  

Depression and anxiety are highly prevalent disorders and represent one of the largest causes of disability worldwide. These results are important as many patients do not respond to current treatments and it has long been recognised that new mechanistic understanding of these disorders would be necessary to in order to identify drugs for treatment-resistant depression.    

The research was funded by the EU-funded Marie Curie Initial Training Network r’BIRTH, the Academy of Finland, Turku Network in Molecular Biosciences and the National Institute on Aging (US). The results were published in the Nature Publishing Group Journal Molecular Psychiatry.   

Link to publication: www.nature.com/mp/journal/vaop/ncurrent/full/mp2016203a.html

Researchers used virus tools to find out where in the brain the JNK inhibitor acted to improve mood. They found out the molecule acts to alleviate anxiety and depression by controlling newly born nerve cells in the hippocampus. The image above, taken at the Cell Imaging Core, shows these new born cells in the hippocampus, the region of the brain that controls emotions.

More information

  • Dr Eleanor Coffey, Research Director, Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, eleanor.coffey(at)btk.fi, tel. +358 2 333 8605

Academy of Finland Communications
Riitta Tirronen, Director of Communications
tel. +358 295 335 118
firstname.lastname(at)aka.fi

Last modified 19 Jan 2017
Connect with us
Facebook Slideshare Twitter Youtube
SWITCHBOARD +358 295 335 000
REGISTRY +358 295 335 049
FAX +358 295 335 299
   
EMAIL firstname.lastname@aka.fi
OFFICE HOURS Mon–Fri 8.00–16.15
   
STAFF DIRECTORY »
CONTACTS & INVOICING »
QUESTIONS & FEEDBACK »